5-Aminoimidazole-4-carboxamide-1-β-ribofuranoside (AICAR) prevents nuclear translocation of constitutive androstane receptor by AMP-activated protein kinase (AMPK) independent manner

Journal of Toxicological Sciences

Volumn 35, Issue 4, 2010, Pages 571-576

  Kanno, Yuichiro ^a   Inoue, Yoshimi ^a   Inouye, Yoshio ^a  

^a TOHO UNIVERSITY   (Japan)

Author keywords

AMP activated protein kinase; Constitutive androstane receptor; Phenobarbital

Indexed keywords

5 AMINOIMIDAZOLE 4 CARBOXAMIDE 1 BETA RIBOFURANOSIDE; CONSTITUTIVE ANDROSTANE RECEPTOR; CYTOCHROME P450 2B; ENZYME ACTIVATOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; METFORMIN; PHENOBARBITAL; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; GENE EXPRESSION; GENE TRANSLOCATION; HUMAN; LIVER CELL; NONHUMAN; RAT; REPORTER GENE;

RATTUS;

EID: 77956829319     PISSN: 03881350     EISSN: 18803989     Source Type: Journal    
DOI: 10.2131/jts.35.571     Document Type: Article

References (18)

1. Baes, M., Gulick, T., Choi, H.S., Martinoli, M.G., Simha, D. and Moore, D.D. (1994): A new orphan member of the nuclear hormone receptor superfamily that interacts with a subset of retinoic acid response elements. Mol. Cell Biol., 14, 1544-1552.
2. Barbara, E.C., Kimberly, S., James, G., Bruce, E.K. and Lee, A.W. (1998): Functional Domains of the α1 Catalytic Subunit of the AMP-activated Protein Kinase. J. Biol. Chem., 273, 35347-35354.
3. Blättler, S.M., Rencurel, F., Kaufmann, M.R. and Meyer, U.A. (2007): In the regulation of cytochrome P450 genes, phenobarbital targets LKB1 for necessary activation of AMP-activated protein kinase. Proc. Natl. Acad. Sci. USA, 104, 1045-1050.
4. Corton, J.M., Gillespie, J.G., Hawley, S.A. and Hardie, D.G. (1995): 5-aminoimidazole-4-carboxamide ribonucleoside. A specific method for activating AMP-activated protein kinase in intact cells? Eur. J. Biochem., 229, 558-565.
5. Guigas, B., Taleux, N., Foretz, M., Detaille, D., Andreelli, F., Viollet, B. and Hue, L. (2007): AMP-activated protein kinase-independent inhibition of hepatic mitochondrial oxidative phosphorylation by AICA riboside. Biochem. J., 404, 499-507.
6. Jacobs, R.L., Lingrell, S., Dyck, J.R. and Vance, D.E. (2007). Inhibition of hepatic phosphatidylcholine synthesis by 5-aminoimidazole-4-carboxamide-1- beta-4-ribofuranoside is independent of AMP-activated protein kinase activation. J. Biol. Chem., 282, 4516-4523.
7. Kanno, Y., Aoki, S., Mochizuki, M., Mori, E., Nakahama, T. and Inouye, Y. (2005a): Expression of constitutive androstane receptor splice variants in rat liver and lung and their functional properties. Biol. Pharm. Bull., 28, 2058-2062.
8. Kanno, Y., Suzuki, M., Nakahama, T. and Inouye, Y. (2005b): Characterization of nuclear localization signals and cytoplasmic retention region in the nuclear receptor CAR. Biochim. Biophys. Acta, 1745, 215-222.
9. Kanno, Y., Suzuki, M., Miyazaki, Y., Matsuzaki, M., Nakahama, T., Kurose, K., Sawada, J. and Inouye, Y. (2007): Difference in nucleocytoplasmic shuttling sequences of rat and human constitutive active/androstane receptor. Biochim. Biophys. Acta, 1773, 934-944.
10. Kawamoto, T., Sueyoshi, T., Zelko, I., Moore, R., Washburn, K. and Negishi, M. (1999): Phenobarbital-responsive nuclear translocation of the receptor CAR in induction of the CYP2B gene. Mol. Cell Biol., 19, 6318-6322.
11. Kobayashi, K., Sueyoshi, T., Inoue, K., Moore, R. and Negishi, M. (2003): Cytoplasmic accumulation of the nuclear receptor CAR by a tetratricopeptide repeat protein in HepG2 cells. Mol. Pharmacol., 64, 1069-1075.
12. Lee-Young, R.S., Griffee, S.R., Lynes, S.E., Bracy, D.P., Ayala, J.E., McGuinness, O.P. and Wasserman, D.H. (2009): Skeletal muscle AMP-activated protein kinase is essential for the metabolic response to exercise in vivo. J. Biol. Chem., 284, 23925-23934.
13. Moore, L.B., Parks, D.J., Jones, S.A., Bledsoe, R.K., Consler, T.G., Stimmel, J.B., Goodwin, B., Liddle, C., Blanchard, S.G., Willson, T.M., Collins, J.L. and Kliewer, S.A. (2000): Orphan nuclear receptors constitutive androstane receptor and pregnane X receptor share xenobiotic and steroid ligands. J. Biol. Chem., 275, 15122-15127.
14. Mutoh, S., Osabe, M., Inoue, K., Moore, R., Pedersen, L., Perera, L., Rebolloso, Y., Sueyoshi, T. and Negishi, M. (2009): Dephosphorylation of threonine 38 is required for nuclear translocation and activation of human xenobiotic receptor CAR (NR1I3). J. Biol. Chem., 284, 34785-34792.
15. Rencurel, F., Stenhouse, A., Hawley, S.A., Friedberg, T., Hardie, D.G., Sutherland, C. and Wolf, C.R. (2005): AMP-activated protein kinase mediates phenobarbital induction of CYP2B gene expression in hepatocytes and a newly derived human hepatoma cell line. J. Biol. Chem., 280, 4367-4373.
16. Rencurel, F., Foretz, M., Kaufmann, M.R., Stroka, D., Looser, R., Leclerc, I., da Silva Xavier, G., Rutter, G.A., Viollet, B. and Meyer, U.A. (2006): Stimulation of AMP-activated protein kinase is essential for the induction of drug metabolizing enzymes by phenobarbital in human and mouse liver. Mol. Pharmacol., 70, 1925-1934.
17. Shindo, S., Numazawa, S. and Yoshida, T. (2007): A physiological role of AMP-activated protein kinase in phenobarbital-mediated constitutive androstane receptor activation and CYP2B induction. Biochem., J. 401, 735-741. (Pubitemid 46219267)
18. Yoshinari, K., Kobayashi, K., Moore, R., Kawamoto, T. and Negishi, M. (2003): Identification of the nuclear receptor CAR: HSP90 complex in mouse liver and recruitment of protein phosphatase 2A in response to phenobarbital. FEBS Lett., 548, 17-20. (Pubitemid 37281243)